Immunoscore Refines CRC Prognosis, Therapy - Top-Institutions - MDSpire

Immunoscore Refines CRC Prognosis, Therapy

Despite a strong evidence base, the assay has not been widely implemented in routine clinical practice.

  • By

  • Doug Brunk

  • January 7, 2026

  • 4 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    INSERM (French National Institute of Health and Medical Research)
    INSERM (French National Institute of Health and Medical Research)

    Paris, Île-de-France

    Key Differentiators

    • Oncology
    • Immunology
    • Pathology

  • #2

    The University of Hong Kong, School of Clinical Medicine
    The University of Hong Kong, School of Clinical Medicine

    Hong Kong, Hong Kong SAR

    Key Differentiators

    • Pathology
    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Surgical Oncology
    • Immunotherapy

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Pathology

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology
    • Immunology

Original Source(s)

Immunoscore Refines CRC Prognosis, Therapy

  • by Doug Brunk

  • January 7, 2026

Related Content

Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy: The OCULUS Randomized Clinical Trial

Editorial: Insights into gastrointestinal cancer metastasis from preclinical models

Small-cell neuroendocrine carcinoma of the descending colon in a young adult: a case report